HCV Basic Science
Researchers Show How Cholesterol Receptor Promotes HCV Cell Entry
- Details
- Category: HCV Basic Science
- Published on Friday, 27 January 2012 00:00
- Written by Press Release
A molecule in liver cell membranes that plays a role in cholesterol uptake also enables hepatitis C virus (HCV) to enter cells, according to research reported in the January 8, 2012, advance online edition of Nature Medicine.
Hepatitis A Immune Response Has Implications for Hepatitis C
- Details
- Category: HCV Basic Science
- Published on Friday, 08 July 2011 13:19
- Written by Southwest Foundation for Biomedical Research
Hepatitis A virus appears to evade immune defenses better than hepatitis C virus, even though it only causes short-term illness. Learning about differences between viral dynamics and immune response to HAV and HCV may offer information that can inform treatment.
Statins May Increase Antiviral Activity of Hepatitis C Therapies and Delay Development of Resistance
- Details
- Category: HCV Treatment
- Published on Tuesday, 11 August 2009 14:01
- Written by Liz Highleyman
Statin drugs, typically used to manage high cholesterol, reduced hepatitis C virus (HCV) replication and increased the activity of interferon and directly-targeted anti-HCV agents in laboratory studies, and prevented development of resistance, according to a report in the July 2009 issue of Hepatology.
MIT and Rockefeller University Researchers Develop Method for Growing Hepatitis C Virus in Healthy Human Liver Cells
- Details
- Category: HCV Basic Science
- Published on Friday, 05 February 2010 13:02
- Written by MIT
Research on the lifecycle of hepatitis C virus (HCV) and development of effective therapies has been hampered by the fact that the virus is difficult to grow in liver cells in the laboratory; instead, investigators have used "replicon" models or a specific strain of HCV in cancerous liver cells. But now, researchers at the Massachusetts Institute of Technology (MIT) and Rockefeller University have found a way to sustain viral replication for up to 3 weeks in healthy liver cells, as reported in the February 1, 2010 advance online issue of Proceedings of the National Academy of Sciences.
Methamphetamine Promotes Hepatitis C Virus Replication in Human Liver Cells
- Details
- Category: HCV Basic Science
- Published on Friday, 07 March 2008 13:03
- Written by HIVandHepatitis.com
While there have been numerous studies of hepatitis C in individuals who inject drugs (primarily heroin), less is known about the effects of non-injection drugs on hepatitis C virus (HCV) infection. Methamphetamine is a stimulant that may be taken as a pill, injected, snorted, smoked, or administered anally. In the April 2008 Journal of Viral Hepatitis, L. Ye of the University of Pennsylvania School of Medicine and colleagues reported on a laboratory study looking at whether methamphetamine inhibits innate immunity in host cells, thereby facilitating HCV replication in human hepatocytes (liver cells).
Web Design and Development by